The CELLEX is comparable to the UVAR-XTS for the treatment of acute and chronic graft versus host disease (GVHD).
Amber AfzalMaryna TarbunovaGeorge DespotisBrenda J GrossmanPublished in: Transfusion (2020)
The efficacy and safety of the two ECP instruments, the CELLEX and the UVAR-XTS, are comparable for the treatment of acute and chronic GVHD.